Special notice
Advanced Development of OXOS X3, a Point-of-Care Diagnostic X-Ray Imaging System for Detection of Fracture and other Trauma
75A50126C00011
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$9,574,160.61 obligated so far on USAspending
Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities
This one was awarded in 2026
18 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Development/Production - Kidney GEC-Specific AAV Vector
Department of Veterans Affairs, Rpo East
Sources soughtNAICS 541714Columbia, MO36C24E27Q0009Closes in 4 daysNov 4 - AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 5 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 6 daysNov 5
All 18 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
Transform trauma response by bringing hospital-grade imaging directly to the point of need by developing and receiving FDA clearance of the OXOS X3, an ultra-portable, high-output general radiography and fluoroscopy system engineered to function as a threatagnostic medical countermeasure (MCM). Designed to weigh under 25 pounds and deliver up to 100 kV / 15 mA at the point of need, X3 augments the transport-to-imaging bottleneck that currently degrades survival in mass casualty incidents (MCIs) involving nuclear detonation, conventional blast, or large-scale trauma surge events. By bringing hospital-grade diagnostic capability directly to the casualty, whether in a high-volume Emergency Department, a temporary field hospital, or a triage site, X3 restores the diagnostic foundation of the ATLS primary survey at every step where current portable assets fail.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- SAM Post Award Notification - OXOS (25 Sept 2026).pdf64 KB, September 29, 2026
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Oxos Medical Inc.
- UEI
- D3KFHYMV6B17
- CAGE
- 7P5Y3
- Vendor location
- Atlanta, GA
- Contract
- 75A50126C00011, definitive contract
- Obligated
- $9,574,160.61, current value $24,445,826
- Actions
- 1 between September 25, 2026 and September 25, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Develop and Validate the Oxos X3, a Portable X-Ray System Designed to Transform Trauma Response by Bringing Hospital-Grade Imaging Directly to the Point of Need. This Effort Will Eliminate Critical Triage Bottlenecks During Mass Casualty Incidents WH
- Match
- solicitation number 75A50126C00011 was reused as the contract number; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 29, 2026
Special notice
Due September 25, 2026 at 12:00 AM EDT. SAM.gov, notice 10b23f5dd399446881c691d10e225e80
1 revisions on SAM
- September 29, 2026: publish, special notice
Points of contact
- Erin Greninger, Contracting Officererin.greninger@hhs.gov
- Joann Kambaja, Contract SpecialistJoann.Kambaja@hhs.gov2029135470